The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I trial of fourth-generation chimeric antigen receptor T-cells targeting glypican-3 for advanced hepatocellular carcinoma.
 
Weijia Fang
No Relationships to Disclose
 
Qihan Fu
No Relationships to Disclose
 
Qingwei Zhao
No Relationships to Disclose
 
Yi Zheng
No Relationships to Disclose
 
Lulu Liu
No Relationships to Disclose
 
Zonghai Li
Employment - CARsgen Therapeutics
Leadership - CARsgen Therapeutics
Stock and Other Ownership Interests - CARsgen Therapeutics
Honoraria - CARsgen Therapeutics
Consulting or Advisory Role - CARsgen Therapeutics
Speakers' Bureau - CARsgen Therapeutics
Research Funding - CARsgen Therapeutics
Patents, Royalties, Other Intellectual Property - CARsgen Therapeutics
Expert Testimony - CARsgen Therapeutics
Travel, Accommodations, Expenses - CARsgen Therapeutics
Other Relationship - CARsgen Therapeutics
(OPTIONAL) Uncompensated Relationships - CARsgen Therapeutics
 
Xiaomeng Dai
No Relationships to Disclose
 
Huamao Wang
Employment - CARsgen Therapeutics
Leadership - CARsgen Therapeutics
Stock and Other Ownership Interests - CARsgen Therapeutics
Honoraria - CARsgen Therapeutics
Consulting or Advisory Role - CARsgen Therapeutics
Speakers' Bureau - CARsgen Therapeutics
Research Funding - CARsgen Therapeutics
Patents, Royalties, Other Intellectual Property - CARsgen Therapeutics
Expert Testimony - CARsgen Therapeutics
Travel, Accommodations, Expenses - CARsgen Therapeutics
Other Relationship - CARsgen Therapeutics
(OPTIONAL) Uncompensated Relationships - CARsgen Therapeutics
 
Xudong Zhu
No Relationships to Disclose
 
Peng Zhao
No Relationships to Disclose
 
Meihua Lin
No Relationships to Disclose
 
Hangyu Zhang
No Relationships to Disclose
 
Jun Xiao
Employment - CARsgen Therapeutics
Leadership - CARsgen Therapeutics
Stock and Other Ownership Interests - CARsgen Therapeutics
Honoraria - CARsgen Therapeutics
Consulting or Advisory Role - CARsgen Therapeutics
Speakers' Bureau - CARsgen Therapeutics
Research Funding - CARsgen Therapeutics
Patents, Royalties, Other Intellectual Property - CARsgen Therapeutics
Expert Testimony - CARsgen Therapeutics
Travel, Accommodations, Expenses - CARsgen Therapeutics
Other Relationship - CARsgen Therapeutics
 
Jian Liu
No Relationships to Disclose
 
Zhou Tong
No Relationships to Disclose
 
Zhen Wang
Employment - CARsgen Therapeutics
Leadership - CARsgen Therapeutics
Stock and Other Ownership Interests - CARsgen Therapeutics
Honoraria - CARsgen Therapeutics
Consulting or Advisory Role - CARsgen Therapeutics
Speakers' Bureau - CARsgen Therapeutics
Research Funding - CARsgen Therapeutics
Patents, Royalties, Other Intellectual Property - CARsgen Therapeutics
Expert Testimony - CARsgen Therapeutics
Travel, Accommodations, Expenses - CARsgen Therapeutics
Other Relationship - CARsgen Therapeutics
 
Tingbo Liang
No Relationships to Disclose